MCK250117P625000
- 0.00
- 0.000.00%
McKesson Newsroom
Citi Maintains McKesson(MCK.US) With Buy Rating, Cuts Target Price to $677
Citigroup Adjusts Price Target on McKesson to $677 From $713, Maintains Buy Rating
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
TD Cowen Maintains McKesson(MCK.US) With Buy Rating, Raises Target Price to $695
TD Cowen Reaffirms Their Buy Rating on McKesson (MCK)
McKesson (MCK) Gains As Market Dips: What You Should Know
Headline Risks Affecting Healthcare Tech & Distribution Sector Will Likely Continue in 2025: BofA Analyst
McKesson Is Maintained at Buy by B of A Securities
McKesson Analyst Ratings
Cardinal Health Upgraded to Buy by BofA
Express News | Mckesson Corp : BofA Global Research Cuts Price Objective to $650 From $680
After experiencing a bumper harvest in 2024, the USA ETF may encounter setbacks this year.
The USA Exchange Traded Fund (ETF) received a record inflow of $1.1 trillion in 2024, but entering 2025, rapid growth may face more obstacles.
Jim Cramer's Take on McKesson Corporation (MCK): Bold Predictions for the Future
Express News | Mckesson Corporation Completes Divestiture of Canada-Based Rexall and Well.ca Businesses
McKesson Corporation Completes Divestiture of Canada-Based Rexall and Well.ca Businesses
Why McKesson (MCK) Is a Top Value Stock for the Long-Term
Investing in McKesson (NYSE:MCK) Five Years Ago Would Have Delivered You a 333% Gain
Press Release: McKesson Corporation Announces Third Quarter Fiscal 2025 Earnings Release Date and Participation in January Conference
Investors Heavily Search McKesson Corporation (MCK): Here Is What You Need to Know
Healthcare and Medical Simulation Market Size Expected to Reach USD 7.04 Bn by 2034